or Try an Advanced Search...

    Advanced Solid Tumors Stocks List

    Symbol Grade Name % Change
    STTK A Shattuck Labs, Inc. 6.08
    ADCT B ADC Therapeutics SA -0.90
    CRDF B Cardiff Oncology, Inc. 2.26
    HOWL C Werewolf Therapeutics, Inc. 5.48
    CLRB D Cellectar Biosciences, Inc. 2.98
    ELEV D Elevation Oncology, Inc. 2.33
    PPBT F Purple Biotech Ltd. -3.10
    RLAY F Relay Therapeutics, Inc. 3.98
    CASI F CASI Pharmaceuticals, Inc. 6.28
    SLRX F Salarius Pharmaceuticals, Inc. -4.71
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Cancer Solid Tumors Biotechnology Clinical Medicine Medicine Life Sciences Treatment Of Cancer Antineoplastic Drugs Cancer Treatment Lymphoma Oncology Ovarian Cancer Autoimmune Disease Biopharmaceutical Chemotherapy Drugs Health Sciences Leukemia Metastatic Solid Tumors Pharmaceutical

    Related ETFs - A few ETFs which own one or more of the above listed Advanced Solid Tumors stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 1.11
    LRNZ C TrueMark Technology, AI & Deep Learning ETF 0.85
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.5
    XBI D SPDR S&P Biotech ETF 0.38
    LABU F Direxion Daily S&P Biotech Bull 3X Shares 0.24
    View all Advanced Solid Tumors ETFs...
    Compare ETFs
    Compare BBC to LABU Compare BBC to XBI Compare CNCR to LRNZ

        Advanced Solid Tumors Stocks Recent News

        Date Stock Title
        Apr 25 CRDF Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
        Apr 25 RLAY Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
        Apr 25 PPBT Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
        Apr 24 HOWL Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
        Apr 23 HOWL Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
        Apr 22 ELEV Elevation Oncology: Continuing To Seek Footing As It Climbs (Rating Upgrade)
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Cancer Solid Tumors Biotechnology Clinical Medicine Medicine Life Sciences Treatment Of Cancer Antineoplastic Drugs Cancer Treatment Lymphoma Oncology Ovarian Cancer Autoimmune Disease Biopharmaceutical Chemotherapy Drugs Health Sciences Leukemia Metastatic Solid Tumors Pharmaceutical
        Advanced Solid Tumors

        Advanced solid tumors are cancerous tumors that have spread beyond the original site of the tumor and have become more difficult to treat. These tumors are often referred to as metastatic or stage IV tumors. Advanced solid tumors can affect any part of the body and can be caused by a variety of different types of cancer. Treatment options for advanced solid tumors may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and/or clinical trials.

        Browse All Tags